1620 Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $653K | Buy |
14,109
+294
| +2% | +$13.6K | 0.46% | 64 |
|
|
2025
Q1 | $843K | Buy |
13,815
+117
| +0.9% | +$7.14K | 0.64% | 32 |
|
|
2024
Q4 | $775K | Buy |
13,698
+4,407
| +47% | +$249K | 0.59% | 41 |
|
|
2024
Q3 | $481K | Sell |
9,291
-1,490
| -14% | -$77.1K | 0.35% | 89 |
|
|
2024
Q2 | $448K | Sell |
10,781
-6,393
| -37% | -$265K | 0.34% | 85 |
|
|
2024
Q1 | $931K | Buy |
17,174
+16,646
| +3,153% | +$903K | 0.94% | 30 |
|
|
2023
Q4 | $589K | Sell |
528
-9,491
| -95% | -$10.6M | 0.64% | 52 |
|
|
2023
Q3 | $582K | Sell |
10,019
-78
| -0.8% | -$4.53K | 0.66% | 49 |
|
|
2023
Q2 | $646K | Buy |
10,097
+201
| +2% | +$12.9K | 0.7% | 46 |
|
|
2023
Q1 | $686K | Buy |
9,896
+70
| +0.7% | +$4.85K | 0.83% | 40 |
|
|
2022
Q4 | $707K | Buy |
9,826
+121
| +1% | +$8.71K | 0.86% | 40 |
|
|
2022
Q3 | $690K | Buy |
9,705
+83
| +0.9% | +$5.9K | 1.02% | 29 |
|
|
2022
Q2 | $741K | Buy |
9,622
+497
| +5% | +$38.3K | 1.02% | 30 |
|
|
2022
Q1 | $569K | Hold |
9,125
| – | – | 0.62% | 61 |
|
|
2021
Q4 | $569K | Buy |
+9,125
| New | +$569K | 0.64% | 58 |
|